vs
Side-by-side financial comparison of Amplify Energy Corp. (AMPY) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $56.6M, roughly 1.3× Amplify Energy Corp.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -18.1%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -13.9%).
Amplify Energy Corp is a crude oil company based in Houston, Texas, USA. The company was founded in 2017, and is traded on the New York Stock Exchange.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
AMPY vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.6M | $75.5M |
| Net Profit | $64.4M | — |
| Gross Margin | 93.7% | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 113.9% | — |
| Revenue YoY | -18.1% | 27.7% |
| Net Profit YoY | 967.0% | — |
| EPS (diluted) | $1.55 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.6M | $75.5M | ||
| Q3 25 | $66.4M | $54.5M | ||
| Q2 25 | $68.4M | $52.4M | ||
| Q1 25 | $72.0M | $46.0M | ||
| Q4 24 | $69.0M | $59.1M | ||
| Q3 24 | $69.9M | $80.5M | ||
| Q2 24 | $79.5M | $47.1M | ||
| Q1 24 | $76.3M | $43.8M |
| Q4 25 | $64.4M | — | ||
| Q3 25 | $-21.0M | $8.8M | ||
| Q2 25 | $6.4M | $5.9M | ||
| Q1 25 | $-5.9M | $3.0M | ||
| Q4 24 | $-7.4M | — | ||
| Q3 24 | $22.7M | $20.3M | ||
| Q2 24 | $7.1M | $-4.5M | ||
| Q1 24 | $-9.4M | $-4.8M |
| Q4 25 | 93.7% | 69.3% | ||
| Q3 25 | 92.1% | 77.7% | ||
| Q2 25 | 93.1% | 76.5% | ||
| Q1 25 | 94.1% | 77.1% | ||
| Q4 24 | 93.5% | 76.4% | ||
| Q3 24 | 93.9% | 63.9% | ||
| Q2 24 | 93.8% | 77.4% | ||
| Q1 24 | 93.7% | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | -39.9% | 17.6% | ||
| Q2 25 | 18.4% | 12.7% | ||
| Q1 25 | -5.5% | 8.7% | ||
| Q4 24 | -9.6% | 22.6% | ||
| Q3 24 | 46.7% | 27.4% | ||
| Q2 24 | 17.0% | -4.6% | ||
| Q1 24 | -11.9% | -5.3% |
| Q4 25 | 113.9% | — | ||
| Q3 25 | -31.6% | 16.2% | ||
| Q2 25 | 9.3% | 11.2% | ||
| Q1 25 | -8.1% | 6.5% | ||
| Q4 24 | -10.8% | — | ||
| Q3 24 | 32.4% | 25.2% | ||
| Q2 24 | 9.0% | -9.6% | ||
| Q1 24 | -12.3% | -11.0% |
| Q4 25 | $1.55 | $0.26 | ||
| Q3 25 | $-0.52 | $0.17 | ||
| Q2 25 | $0.15 | $0.12 | ||
| Q1 25 | $-0.15 | $0.06 | ||
| Q4 24 | $-0.16 | $0.40 | ||
| Q3 24 | $0.54 | $0.41 | ||
| Q2 24 | $0.17 | $-0.09 | ||
| Q1 24 | $-0.24 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.7M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $458.7M | $130.3M |
| Total Assets | $600.9M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.7M | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | $502.0K | $96.8M | ||
| Q1 24 | $3.0M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $458.7M | $130.3M | ||
| Q3 25 | $393.0M | $115.3M | ||
| Q2 25 | $411.3M | $104.7M | ||
| Q1 25 | $402.9M | $97.1M | ||
| Q4 24 | $408.9M | $92.1M | ||
| Q3 24 | $414.7M | $71.1M | ||
| Q2 24 | $390.3M | $48.5M | ||
| Q1 24 | $381.0M | $51.0M |
| Q4 25 | $600.9M | $216.3M | ||
| Q3 25 | $731.4M | $202.9M | ||
| Q2 25 | $771.3M | $194.9M | ||
| Q1 25 | $753.6M | $196.2M | ||
| Q4 24 | $747.1M | $213.3M | ||
| Q3 24 | $739.2M | $220.7M | ||
| Q2 24 | $720.4M | $205.0M | ||
| Q1 24 | $712.2M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.4M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -0.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-13.4M | $14.4M | ||
| Q3 25 | $13.4M | $9.7M | ||
| Q2 25 | $23.7M | $14.1M | ||
| Q1 25 | $25.5M | $3.6M | ||
| Q4 24 | $12.5M | $15.6M | ||
| Q3 24 | $15.7M | $11.0M | ||
| Q2 24 | $15.4M | $1.0M | ||
| Q1 24 | $7.7M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | -0.21× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 3.71× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.69× | 0.54× | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMPY
| Oil And Gas | $54.7M | 97% |
| Other | $1.8M | 3% |
PBYI
Segment breakdown not available.
